U.S., Dec. 4 -- ClinicalTrials.gov registry received information related to the study (NCT07262645) titled 'Near-infrared Light Therapy Device for Mild-Moderate Alzheimer's Disease (NirsCure-03A)' on Nov. 21.
Brief Summary: This study is a multicenter, randomized, double-blind, placebo (sham device)-controlled clinical trial.
A total of 320 patients with mild to moderate Alzheimer's disease (AD) are planned to be enrolled. Central stratified block randomization will be applied, with stratification based on disease severity (mild vs. moderate) and PET subgroup participation status (yes vs. no). Participants will be randomly assigned to either the treatment group or control group in a 1:1 ratio. After enrollment, participants will complete ...